HomeCTOR • NASDAQ
add
Citius Oncology Inc
Previous close
$1.89
Day range
$1.83 - $1.96
Year range
$0.55 - $6.19
Market cap
159.51M USD
Avg Volume
237.68K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.94M | 6.83% |
Net income | -5.37M | -12.51% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | -5.18% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 112.00 | — |
Total assets | 91.71M | 83.39% |
Total liabilities | 59.31M | 79.86% |
Total equity | 32.40M | — |
Shares outstanding | 78.37M | — |
Price to book | 4.20 | — |
Return on assets | -13.50% | — |
Return on capital | -32.69% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -5.37M | -12.51% |
Cash from operations | 0.00 | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | 1.91M | 10.30% |
About
Founded
2021
Headquarters
Website
